Multiple international authorities including AABB,British Society for Haematology and World Health Organization consistently recommend irradiation as the standard preventive measure for TA-GVHD in at-risk populations, including:

• Recipients of hematopoietic stem cell transplantation (HSCT) 

• Patients with hematological malignancies 

• Individuals with congenital or acquired immunodeficiency 

• Patients receiving purine analogs or intensive immunosuppressive therapy 

• Patients undergoing CAR-T cell therapy 

• Intrauterine transfusion (IUT) and neonatal exchange transfusion 

• Transfusions from first-degree relatives (directed donations) 

• HLA-matched platelet transfusions

• Prevention of TA-GVHD

 Designed for blood stations and hospitals to prevent transfusion-associated graft-versus-host disease (TA-GVHD) through blood irradiation.

• Pioneering X-Ray Blood Irradiator

China’s first X-ray blood irradiator, much more environmental friendly, setting a new benchmark in transfusion safety.

• World’s First Dual-Mode Irradiation System

 X-RAD 8000 supports both batch and rapid irradiation to meet diverse clinical scenarios.

• Self-Shielded, Easy Installation

 Built-in shielding eliminates the need for additional room protection, saving time and effort.